Cargando…
Intestinal and Hepatic Niemann-Pick C1-Like 1
Polytopic transmembrane protein, Niemann-Pick C1-Like 1 (NPC1L1) is localized at the apical membrane of enterocytes and the canalicular membrane of hepatocytes. It mediates intestinal cholesterol absorption and prevents extensive loss of cholesterol by transporting biliary cholesterol into hepatocyt...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753488/ https://www.ncbi.nlm.nih.gov/pubmed/23991401 http://dx.doi.org/10.4093/dmj.2013.37.4.240 |
_version_ | 1782281839878078464 |
---|---|
author | Park, Sung-Woo |
author_facet | Park, Sung-Woo |
author_sort | Park, Sung-Woo |
collection | PubMed |
description | Polytopic transmembrane protein, Niemann-Pick C1-Like 1 (NPC1L1) is localized at the apical membrane of enterocytes and the canalicular membrane of hepatocytes. It mediates intestinal cholesterol absorption and prevents extensive loss of cholesterol by transporting biliary cholesterol into hepatocytes. NPC1L1 is a molecular target of ezetimibe, an agent for hypercholesterolemia. Recently, NPC1L1 inhibition has been shown to prevent metabolic disorders such as fatty liver disease, obesity, diabetes, and atherosclerosis. In this review, the identification and characterization of NPC1L1, NPC1L1-dependent cholesterol transport, the relationship with pathogenesis of metabolic disease and its newly introduced function for virus entry are discussed. |
format | Online Article Text |
id | pubmed-3753488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Korean Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-37534882013-08-29 Intestinal and Hepatic Niemann-Pick C1-Like 1 Park, Sung-Woo Diabetes Metab J Sulwon Lecture 2012 Polytopic transmembrane protein, Niemann-Pick C1-Like 1 (NPC1L1) is localized at the apical membrane of enterocytes and the canalicular membrane of hepatocytes. It mediates intestinal cholesterol absorption and prevents extensive loss of cholesterol by transporting biliary cholesterol into hepatocytes. NPC1L1 is a molecular target of ezetimibe, an agent for hypercholesterolemia. Recently, NPC1L1 inhibition has been shown to prevent metabolic disorders such as fatty liver disease, obesity, diabetes, and atherosclerosis. In this review, the identification and characterization of NPC1L1, NPC1L1-dependent cholesterol transport, the relationship with pathogenesis of metabolic disease and its newly introduced function for virus entry are discussed. Korean Diabetes Association 2013-08 2013-08-14 /pmc/articles/PMC3753488/ /pubmed/23991401 http://dx.doi.org/10.4093/dmj.2013.37.4.240 Text en Copyright © 2013 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Sulwon Lecture 2012 Park, Sung-Woo Intestinal and Hepatic Niemann-Pick C1-Like 1 |
title | Intestinal and Hepatic Niemann-Pick C1-Like 1 |
title_full | Intestinal and Hepatic Niemann-Pick C1-Like 1 |
title_fullStr | Intestinal and Hepatic Niemann-Pick C1-Like 1 |
title_full_unstemmed | Intestinal and Hepatic Niemann-Pick C1-Like 1 |
title_short | Intestinal and Hepatic Niemann-Pick C1-Like 1 |
title_sort | intestinal and hepatic niemann-pick c1-like 1 |
topic | Sulwon Lecture 2012 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753488/ https://www.ncbi.nlm.nih.gov/pubmed/23991401 http://dx.doi.org/10.4093/dmj.2013.37.4.240 |
work_keys_str_mv | AT parksungwoo intestinalandhepaticniemannpickc1like1 |